Project IMPACT Immunizations (IMProving America's Communities Together) Scaled Demonstration
| Status: | Recruiting |
|---|---|
| Conditions: | Influenza |
| Therapuetic Areas: | Immunology / Infectious Diseases |
| Healthy: | No |
| Age Range: | 18 - Any |
| Updated: | 12/5/2018 |
| Start Date: | December 12, 2017 |
| End Date: | November 2, 2019 |
| Contact: | Benjamin M Bluml, BPharm |
| Email: | BBLUML@APHANET.ORG |
| Phone: | 202-429-7571 |
The primary objective of this study is to evaluate how implementing an innovative care model
that provides the pharmacist access to a patient's vaccine history at the point-of-care
impacts the pharmacist's ability to identify unmet vaccination needs and increase vaccination
rates for routinely recommended adult vaccinations.
that provides the pharmacist access to a patient's vaccine history at the point-of-care
impacts the pharmacist's ability to identify unmet vaccination needs and increase vaccination
rates for routinely recommended adult vaccinations.
This multi-site study will use a pre-post design with a population-based comparison group to
investigate the impact of implementing an innovative care model on the pharmacist's ability
to identify unmet vaccination needs and increase vaccination rates for routinely recommended
adult vaccinations. The innovative care model enables the pharmacist to utilize a
bi-directional IIS to assess patients' vaccination histories, identify unmet vaccination
needs, and document the care provided. The project duration has been established to allow
sufficient time for each pharmacy to implement the innovative care model and monitor each
pharmacy for a 6-month study period. The American Pharmacists Association (APhA) Foundation
has an a priori intent to publish the project results.
investigate the impact of implementing an innovative care model on the pharmacist's ability
to identify unmet vaccination needs and increase vaccination rates for routinely recommended
adult vaccinations. The innovative care model enables the pharmacist to utilize a
bi-directional IIS to assess patients' vaccination histories, identify unmet vaccination
needs, and document the care provided. The project duration has been established to allow
sufficient time for each pharmacy to implement the innovative care model and monitor each
pharmacy for a 6-month study period. The American Pharmacists Association (APhA) Foundation
has an a priori intent to publish the project results.
Inclusion Criteria:
- Individuals eligible to be enrolled in the study include any person at least 18 years
of age who is eligible for a comprehensive vaccination history review as determined by
the pharmacist.
Exclusion Criteria:
We found this trial at
22
sites
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials